Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guides
Guidance and tools
Shares
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks Stock plan guidance
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
Director dealings: Smith & Nephew board members invest, Galliford Try CFO covers tax bill
(Sharecast News) - Smith & Nephew and Galliford Try both disclosed share dealings involving senior management and board associates on Friday. At Smith & Nephew, chief corporate strategy and development officer Ajay Dhankhar purchased 18,460 American depositary shares in the medical technology group at $32.58 each, for a total consideration of roughly $602,000.
In a separate transaction, Kagama Family Investments LP, an entity linked to independent non-executive director Garheng Kong, acquired 3,000 shares at $33.98 apiece, worth just over $100,000.
Both transactions took place on 6 November on the New York Stock Exchange.
The purchases followed a steep share price decline this week after Smith & Nephew reported third-quarter revenue of $1.5bn, missing analyst estimates of $1.51bn due to weaker US knee implant sales.
Shares in the London-listed group fell nearly 9% on Thursday after the update, raising concerns about demand trends in key surgical markets despite solid growth in other product lines.
Meanwhile, Galliford Try said its chief financial officer Kris Hampson was issued 9,518 ordinary shares on 5 November under a buy-out award compensating for incentives forfeited at his previous employer.
He later sold 4,474 shares at 376.7p each to cover tax liabilities, with the shares repurchased by the company's employee benefit trust.
The dealings came as analyst sentiment around Galliford Try remained steady, with a consensus price target of about 598p according to Simply Wall St.
Galliford Try had also continued to expand its order pipeline, having recently secured positions on all seven lots of a £3bn affordable homes framework with the Hyde Group.
The five-year programme would deliver about 1,500 homes annually across London, the South and East of England - a move chief executive Bill Hocking said aligned with the company's Sustainable Growth Strategy to 2030.
Reporting by Josh White for Sharecast.com.
Top Director Buys
Smith & Nephew (SN.) Director name: Kong,Garheng Amount purchased: 3,000 @ $33.98 Value: $84,053.68
Central Asia Metals (CAML) Director name: Ferrar,Gavin Amount purchased: 12,669 @ 157.82p Value: £19,993.96
Avon Technologies (AVON) Director name: Cashin,Rich Amount purchased: 8 @ 1,904.00p Value: £152.32
Avon Technologies (AVON) Director name: Sclater,Jos Amount purchased: 8 @ 1,904.00p Value: £152.32
(ITH) Director name: Lewis,Iain Clifford Scobbie Amount purchased: 66 @ 228.00p Value: £150.48
(ITH) Director name: Friedman ,Yaniv Amount purchased: 66 @ 228.00p Value: £150.48
(ITH) Director name: Vasques ,Luciano Amount purchased: 65 @ 228.00p Value: £148.20
Top Director Sells
Bank Of Ireland Group (cdi) (BIRG) Director name: O'Grady,Myles Amount sold: 5,118 @ 14.46 Value: 74,026.24
Bank Of Ireland Group (cdi) (BIRG) Director name: Spain ,Mark Amount sold: 3,232 @ 14.46 Value: 46,747.32
Galliford Try (GFRD) Director name: Hampson ,Kris Amount sold: 4,474 @ 376.70p Value: £16,853.56
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Award-winning online share dealing
Search, compare and select from thousands of shares.
Expert insights into investing your money
Our team of experts explore the world of share dealing.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity, Equity & Inclusion | Diversity, Equity & Inclusion Reports | Doing Business with Fidelity | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Staying secure | Statutory and Regulatory disclosures | Whistleblowing programme
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.